Patents by Inventor Thierry Maugard

Thierry Maugard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals
    Patent number: 11191744
    Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: December 7, 2021
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Vivien Chavanelle, Florian Le Joubioux, Pascal Sirvent, Thierry Maugard
  • Compositions and methods for controlling carbohydrate and fat metabolism
    Patent number: 10736930
    Abstract: A composition comprising at least: a single extract obtained from a mixture of at least two plants selected from Chrysanthellum indicum, Cynara scolymus, Vaccinium myrtillus, Piper and Olea europaea. This composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Grant
    Filed: October 30, 2018
    Date of Patent: August 11, 2020
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • PHARMACEUTICAL ACTIVE INGREDIENT AND USE THEREOF, IN PARTICULAR FOR THE PREVENTION AND TREATMENT OF METABOLIC DISORDERS IN HUMANS AND ANIMALS
    Publication number: 20200009101
    Abstract: The invention relates to an active pharmaceutical ingredient consisting exclusively of the combination of (1S,3R,4R,5R)-3-{[(2E)-3-(3,4-)dihydroxyphenyl)-2-propenoyl]oxy}-1,4,5-trihydroxycyclohexanecarboxylic acid and of methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(?-D-glucopyranosyloxy)-3,4-dihydro-2H -pyran-5-carboxylate for use as a drug or veterinary product, particularly in the prevention and/or treatment of pathological disorders of carbohydrate and/or lipid metabolism.
    Type: Application
    Filed: February 13, 2018
    Publication date: January 9, 2020
    Inventors: Sebastien PELTIER, Vivien CHAVANELLE, Florian LE JOUBIOUX, Pascal SIRVENT, Thierry MAUGARD
  • Compositions for preventing and/or treating pathological conditions associated with alpha-glucosidase
    Patent number: 10500245
    Abstract: A composition including at least one XAP peptide, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase. Also, the use of a hydrolysate of at least one protein, the protein including or constituted by at least 0.05% to <5% or of at least 5% of XAP units, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: December 10, 2019
    Assignees: UNIVERSITE DE LA ROCHELLE, UNIVERSITE CLERMONT AUVERGNE
    Inventors: Thierry Maugard, Stephanie Bordenave-Juchereau, Jean-Marie Piot, Yesmine Ben-Henda, Pascal Sirvent, Sebastien Peltier
  • NOVEL ACTIVE IMMUNOMODULATORY AGENT AND COMPOSITION CONTAINING SAME
    Publication number: 20190183922
    Abstract: Disclosed is a sulphated polysaccharide extracted from a red alga of the Haliptilon subulatum species or a salt thereof as active ingredient. More particularly, the present application relates to a sulphated polysaccharide extracted from a red alga of the Haliptilon subulatum species or a salt thereof as active ingredient, for its use in the modulation of the immune response in humans or animals, in particular in the prevention and/or treatment of inflammatory diseases, in particular of the skin.
    Type: Application
    Filed: August 28, 2017
    Publication date: June 20, 2019
    Inventors: Cédric DELATTRE, Philippe MICHAUD, Guillaume PIERRE, Nicolas BRIDIAU, Thierry MAUGARD, Taratra Andrée FENORADOSOA, Hernas Martial RAKOTOARISOA
  • Compositions and methods for controlling carbohydrate and fat metabolism
    Patent number: 10232005
    Abstract: A composition comprising at least a mixture of molecules obtained at least from: Chrysanthellum indicum, Cynara scolymus, and Vaccinium myrtillus and wherein the mixture of molecules also comprises piperine. The composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: March 19, 2019
    Assignees: Universite Clermont Auvergne, Valbiotis, Universite De La Rochelle, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • COMPOSITIONS AND METHODS FOR CONTROLLING CARBOHYDRATE AND FAT METABOLISM
    Publication number: 20190060383
    Abstract: A composition comprising at least: a single extract obtained from a mixture of at least two plants selected from Chrysanthellum indicum, Cynara scolymus, Vaccinium myrtillus, Piper and Olea europaea. This composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Application
    Filed: October 30, 2018
    Publication date: February 28, 2019
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • Compositions and methods for treating diabetes, fatty liver, cardiopathies, insulin resistance, carbohydrate and fat metabolism
    Patent number: 9962420
    Abstract: This disclosure provides compositions formulated in the form of tablets, wafer capsules, gel capsules, sticks, sachets, vials, droppers or in injectable form. The compositions comprise a mixture of: an extract of Chrysanthellum indicum, an extract of Cynara scolymus, an extract of Vaccinium myrtillus, an extract of Olea europaea, and pipeline. This disclosure also provides methods of treating pathological disorders of carbohydrate and/or fat metabolism in a patient by administering to the patient the compositions.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: May 8, 2018
    Assignees: VALBIOTIS, UNIVERSITE CLERMONT AUVERGNE, UNIVERSITE DE LA ROCHELLE, CNRS
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • COMPOSITIONS FOR PREVENTING AND/OR TREATING PATHOLOGICAL CONDITIONS ASSOCIATED WITH ALPHA-GLUCOSIDASE
    Publication number: 20180104303
    Abstract: A composition including at least one XAP peptide, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase. Also, the use of a hydrolysate of at least one protein, the protein including or constituted by at least 0.05% to <5% or of at least 5% of XAP units, in which X represents the empty set or a valine, for use in the prevention and/or treatment of pathologies associated with alpha-glucosidase.
    Type: Application
    Filed: February 18, 2015
    Publication date: April 19, 2018
    Inventors: Thierry MAUGARD, Stephanie BORDENAVE-JUCHEREAU, Jean-Marie PIOT, Yesmine BEN-HENDA, Pascal SIRVENT, Sebastien PELTIER
  • COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM
    Publication number: 20170028004
    Abstract: The subject of the invention is a composition comprising at least a mixture of molecules obtained at least from: Chrysanthellum indicum, and Cynara scolymus, and Vaccinium myrtillus, said mixture of molecules also comprising piperine. This composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Application
    Filed: October 18, 2016
    Publication date: February 2, 2017
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard
  • COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM
    Publication number: 20160106793
    Abstract: The subject of the invention is a composition comprising at least a mixture of molecules obtained at least from: Chrysanthellum indicum, and Cynara scolymus, and Vaccinium myrtillus, said mixture of molecules also comprising piperine. This composition is particularly useful as a nutritional product or health product for preventing and/or combating carbohydrate and/or fat metabolism disorders in humans and animals.
    Type: Application
    Filed: October 20, 2015
    Publication date: April 21, 2016
    Inventors: Sebastien Peltier, Pascal Sirvent, Thierry Maugard